Svoronos Dawn
SEC-identified person · CIK 1574579 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Xenon Pharmaceuticals Inc. XENE | Director | filed 2016 - 2026 |
| Avalanche Biotechnologies, Inc. [AAVL] | Director | filed 2020 - 2025 |
| Acelyrin, Inc. SLRN | Director | filed 2023 - 2025 |
| Global Blood Therapeutics, Inc. GBT | Director | filed 2018 - 2022 |
| PTC Therapeutics, INC. PTCT | Director | filed 2016 - 2022 |
| Endocyte INC ECYT | Director | filed 2018 - 2018 |
| Medivation, INC. MDVN.OB | Director | filed 2013 - 2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.